首页|脑脊液TREM-1、MCP-1与动脉瘤性蛛网膜下腔出血患者手术治疗转归的关系

脑脊液TREM-1、MCP-1与动脉瘤性蛛网膜下腔出血患者手术治疗转归的关系

扫码查看
目的:探讨脑脊液髓样细胞触发受体-1(TREM-1)、单核细胞趋化蛋白-1(MCP-1)与动脉瘤性蛛网膜下腔出血(aSAH)患者手术治疗转归的关系。方法:选择294例aSAH患者,术前检测脑脊液TREM-1、MCP-1水平。出院后随访3个月,采用改良Rankin量表(mRS)评估患者预后,并据此将患者分为转归不良组(103例)和转归良好组(191例)。多因素Logistic回归分析影响aSAH术后转归不良的因素。结果:转归不良组脑脊液TREM-1、MCP-1水平均高于转归良好组(P<0。05)。Hunt-Hess分级Ⅲ~Ⅳ级、并发迟发性脑缺血、TREM-1升高、MCP-1升高是aSAH术后转归不良的危险因素(P<0。05)。结论:aSAH术后转归不良患者血清TREM-1、MCP-1水平升高,是aSAH术后转归不良的危险因素。
Relationship between TREM-1 and MCP-1 in Cerebrospinal Fluid and the Outcome of Surgical Treatment in Patients with Aneurysmal Subarachnoid Hemorrhage
Objective:To investigate the relationship between triggering receptor expressed on myeloid cells-1(TREM-1)and monocyte chemoattractant protein-1(MCP-1)in cerebrospinal fluid and the outcome of surgical treatment in patients with aneurysmal subarachnoid hemorrhage(aS AH).Methods:294 patients with aS AH were selected,the levels of TREM-1 and MCP-1 in cerebrospinal fluid were detected before operation.3 months after discharge,patient outcomes were assessed using the modified Rankin scale(mRS),and patients were divided into poor outcome group(103 cases)and good outcome group(191 cases)according to this.The factors affect-ing the poor outcome after aSAH were analyzed by multivariate logistic regression analysis.Results:The levels of TREM-1 and MCP-1 in cerebrospinal fluid in poor outcome group were higher than those in good outcome group(P<0.05).Hunt-Hess grade Ⅲ~Ⅳ,delayed cerebral ischemia,increased TREM-1 and MCP-1 were risk factors for poor outcome after aSAH(P<0.05).Conclusion:The increase of serum TREM-1 and MCP-1 levels in patients with poor outcome after aSAH are risk factor for poor outcome after aSAH.

Aneurysmal subarachnoid hemorrhageTriggering receptor expressed on myeloid cells-1Monocyte chemotactic pro-tein-1Postoperative outcome

刘雪龙、刘展、王艮卫、陶胜忠、尹梦磊

展开 >

郑州大学第二附属医院神经外科 河南郑州 450000

动脉瘤性蛛网膜下腔出血 髓样细胞触发受体-1 单核细胞趋化蛋白-1 术后转归

2024

现代生物医学进展
黑龙江省森工总医院 哈尔滨医科大学附属第四医院

现代生物医学进展

CSTPCD
影响因子:0.755
ISSN:1673-6273
年,卷(期):2024.24(22)